BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9538881)

  • 1. Immunologic phenotype of hosts orally immunized with corneal alloantigens.
    Ma D; Li XY; Mellon J; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):744-53. PubMed ID: 9538881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditions affecting enhanced corneal allograft survival by oral immunization.
    Ma D; Mellon J; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1835-46. PubMed ID: 9727406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced immunological tolerance against allograft rejection by oral administration of allogeneic antigen linked to cholera toxin B subunit.
    Sun JB; Li BL; Czerkinsky C; Holmgren J
    Clin Immunol; 2000 Nov; 97(2):130-9. PubMed ID: 11027453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
    Peeler JS; Niederkorn JY
    J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral tolerance to myelin basic protein induces regulatory TGF-beta-secreting T cells in Peyer's patches of SJL mice.
    Santos LM; al-Sabbagh A; Londono A; Weiner HL
    Cell Immunol; 1994 Sep; 157(2):439-47. PubMed ID: 7520838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell-mediated immune responses in alloepithelial rejection after murine keratoepithelioplasty.
    Miyazaki D; Inoue Y; Yao YF; Okada AA; Shimomura Y; Hayashi K; Tano Y; Ohashi Y
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2590-7. PubMed ID: 10509654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell subsets in the immune rejection of murine heterotopic corneal allografts.
    Matoba AY; Peeler JS; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1244-54. PubMed ID: 2942516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell mediated responses in a murine model of orthotopic corneal transplantation.
    Joo CK; Pepose JS; Stuart PM
    Invest Ophthalmol Vis Sci; 1995 Jul; 36(8):1530-40. PubMed ID: 7601633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotype, immunological reactivity and cytokine production profile of Peyer's patch cells from mice immunized orally with allogeneic cells.
    Fric J; Krulová M; Zajícová A; Holán V
    Folia Biol (Praha); 2000; 46(3):119-25. PubMed ID: 10925783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the induction of tolerance to alloantigens. I. The abrogation of potentials for delayed-type-hypersensitivity response to alloantigens by portal venous inoculation with allogeneic cells.
    Qian J; Hashimoto T; Fujiwara H; Hamaoka T
    J Immunol; 1985 Jun; 134(6):3656-61. PubMed ID: 2580893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corneal allografts induce cytotoxic T cell but not delayed hypersensitivity responses in mice.
    Peeler J; Niederkorn J; Matoba A
    Invest Ophthalmol Vis Sci; 1985 Nov; 26(11):1516-23. PubMed ID: 2414248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral tolerance to haptens: intestinal epithelial cells from 2,4-dinitrochlorobenzene-fed mice inhibit hapten-specific T cell activation in vitro.
    Galliaerde V; Desvignes C; Peyron E; Kaiserlian D
    Eur J Immunol; 1995 May; 25(5):1385-90. PubMed ID: 7774642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of oral immunization on corneal allograft survival.
    He YG; Mellon J; Niederkorn JY
    Transplantation; 1996 Mar; 61(6):920-6. PubMed ID: 8623161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the induction of tolerance to alloantigens. II. The generation of serum factor(s) able to transfer alloantigen-specific tolerance for delayed-type hypersensitivity by portal venous inoculation with allogeneic cells.
    Fujiwara H; Qian JH; Satoh S; Kokudo S; Ikegami R; Hamaoka T
    J Immunol; 1986 Apr; 136(8):2763-8. PubMed ID: 2420865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulating dendritic cells to optimize mucosal immunization protocols.
    Williamson E; Westrich GM; Viney JL
    J Immunol; 1999 Oct; 163(7):3668-75. PubMed ID: 10490961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alloantigens placed into the anterior chamber of the eye induce specific suppression of delayed-type hypersensitivity but normal cytotoxic T lymphocyte and helper T lymphocyte responses.
    Niederkorn JY; Streilein JW
    J Immunol; 1983 Dec; 131(6):2670-4. PubMed ID: 6196396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of cytotoxic T lymphocytes in corneal allograft rejection.
    Hegde S; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3341-7. PubMed ID: 11006223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different kinetic patterns of cytokine gene expression in vivo in orally tolerant mice.
    Fishman-Lobell J; Friedman A; Weiner HL
    Eur J Immunol; 1994 Nov; 24(11):2720-4. PubMed ID: 7957564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo priming of helper and suppressor T cells by alloantigens. Frequency analysis with the use of an in vitro limiting dilution assay.
    Bianchi AT; Schilham MW; Benner R; Young P; Lefkovits I
    J Immunol; 1987 Oct; 139(8):2524-9. PubMed ID: 2958552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anterior chamber-associated immune deviation promotes corneal allograft survival.
    Niederkorn JY; Mellon J
    Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2700-7. PubMed ID: 8977485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.